These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11518356)

  • 41. Osteoclastogenesis inhibitory factor/osteoprotegerin in synovial fluid from patients with temporomandibular disorders.
    Kaneyama K; Segami N; Nishimura M; Sato J; Suzuki T; Fujimura K
    Int J Oral Maxillofac Surg; 2003 Aug; 32(4):404-7. PubMed ID: 14505625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint.
    Nishimura M; Segami N; Kaneyama K; Suzuki T; Miyamaru M
    Br J Oral Maxillofac Surg; 2002 Feb; 40(1):68-71. PubMed ID: 11883975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early diagnosis of osteoarthrosis of the temporomandibular joint: correlation between arthroscopic diagnosis and keratan sulfate levels in the synovial fluid.
    Israel HA; Saed-Nejad F; Ratcliffe A
    J Oral Maxillofac Surg; 1991 Jul; 49(7):708-11; discussion 712. PubMed ID: 2056369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disorders.
    Ishimaru JI; Oguma Y; Goss AN
    Br J Oral Maxillofac Surg; 2000 Aug; 38(4):354-9. PubMed ID: 10922168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders.
    Kaneyama K; Segami N; Sato J; Nishimura M; Yoshimura H
    Br J Oral Maxillofac Surg; 2004 Jun; 42(3):246-50. PubMed ID: 15121272
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular endothelial growth factor concentrations in synovial fluids of patients with symptomatic internal derangement of the temporomandibular joint.
    Sato J; Segami N; Kaneyama K; Mashiyama Y; Fujimura K; Yoshitake Y
    J Oral Pathol Med; 2005 Mar; 34(3):170-7. PubMed ID: 15689231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of molecular pain biomarkers in temporomandibular joint internal derangement.
    Ernberg M
    J Oral Rehabil; 2017 Jun; 44(6):481-491. PubMed ID: 28054366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevations in synovial fluid plasminogen activator in patients with rheumatoid arthritis.
    Mochan E; Uhl J
    J Rheumatol; 1984 Apr; 11(2):123-8. PubMed ID: 6427461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in synovial fluid of patients with temporomandibular disorders].
    Hu L; Liang XH; Zhu GQ; Hu J; Shi ZD
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Mar; 43(3):160-3. PubMed ID: 18788551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection and preliminary characterization of matrix metalloproteinase activity in temporomandibular joint lavage fluid.
    Zardeneta G; Milam SB; Lee T; Schmitz JP
    Int J Oral Maxillofac Surg; 1998 Oct; 27(5):397-403. PubMed ID: 9804207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the collagen I and fibronectin of temporomandibular joint synovial fluid and discs.
    Natiella JR; Burch L; Fries KM; Upton LG; Edsberg LE
    J Oral Maxillofac Surg; 2009 Jan; 67(1):105-13. PubMed ID: 19070755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of urinary trypsin inhibitor on osteoarthritis.
    Matsuo O; Tanaka S; Kikuchi H
    Thromb Res; 1988 Nov; 52(3):237-45. PubMed ID: 3143165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Free-radical oxidation and superoxide dismutase activity in synovial fluid of patients with temporomandibular disorders.
    Cai HX; Luo JM; Long X; Li XD; Cheng Y
    J Orofac Pain; 2006; 20(1):53-8. PubMed ID: 16483021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of chemerin in the synovial fluid of patients with temporomandibular joint disorders.
    Şimşek Kaya G; Yapıcı Yavuz G; Kızıltunç A
    J Oral Rehabil; 2018 Apr; 45(4):289-294. PubMed ID: 29331039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The expression of vascular endothelial growth factor in synovial tissues in patients with internal derangement of the temporomandibular joint.
    Sato J; Segami N; Suzuki T; Kaneyama K; Yoshitake Y; Nishikawa K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Mar; 93(3):251-6. PubMed ID: 11925532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Specific expression of substance P in synovial tissues of patients with symptomatic, non-reducing internal derangement of the temporomandibular joint: comparison with clinical findings.
    Sato J; Segami N; Yoshitake Y; Kaneyama K; Yoshimura H; Fujimura K; Kitagawa Y
    Br J Oral Maxillofac Surg; 2007 Jul; 45(5):372-7. PubMed ID: 17098338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of temporomandibular joint arthrocentesis on synovial fluid mediator level of tumor necrosis factor-alpha: implications for treatment outcome.
    Emshoff R; Puffer P; Strobl H; Gassner R
    Int J Oral Maxillofac Surg; 2000 Jun; 29(3):176-82. PubMed ID: 10970078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of tissue kallikrein and alpha 1-antitrypsin-tissue kallikrein complexes in synovial fluid of patients with rheumatoid, osteo and psoriatic arthritis.
    Rahman MM; Worthy K; Elson CJ; Dieppe PA; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 3)():389-96. PubMed ID: 1462872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of receptor activator of nuclear factor-kappaB ligand in synovial tissue: comparison with degradation of articular cartilage in temporomandibular joint disorders.
    Kaneyama K; Segami N; Sato J; Yoshimura H; Nishiura R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e12-7. PubMed ID: 17560137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporomandibular joint internal derangement: relationship between joint pain and MR grading of effusion and total protein concentration in the joint fluid.
    Güler N; Uçkan S; Imirzalioğlu P; Açikgözoğlu S
    Dentomaxillofac Radiol; 2005 May; 34(3):175-81. PubMed ID: 15897289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.